AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Usimira Tablet ER

Prescription Icon
Prescription Required

Marketer

Ytiliga Private Limited

Salt Composition

Mirabegron (50mg)

Overview Usimira Tablet ER

Extended-release Usimira tablets manage overactive bladder symptoms such as urinary urgency, frequency, and incontinence. This medication relaxes bladder muscles, improving urine storage capacity. Always follow your doctor's prescribed dosage and duration. Usimira ER tablets may be taken with or without food; swallow whole, avoiding crushing or chewing. Discontinuing treatment prematurely may worsen symptoms; complete the prescribed course for optimal results. Common side effects include constipation, headache, hypertension, rhinitis, urinary tract infection, tachycardia, and arthralgia. Report persistent or bothersome side effects to your physician immediately. Before starting treatment, disclose all other medications and pre-existing conditions, including pregnancy or breastfeeding status. Patients with hepatic or renal impairment require careful monitoring and regular follow-up appointments as directed by their doctor.

Uses of Usimira Tablet ER

Managing symptoms associated with overactive bladder

Major Benefits of Usimira Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for Usimira Tablet ER. Ingest the tablet whole; avoid chewing, crushing, or breaking it. While Usimira Tablet ER can be taken with or without food, consistent timing is recommended for optimal results.

Common Side effects of Usimira Tablet ER:

  • Constipation
  • Headache
  • High blood pressure
  • Nasal inflammation
  • Urinary tract infection
  • Fast heart rate
  • Joint pain

How to use Usimira Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for Usimira Tablet ER. Ingest the tablet whole; avoid chewing, crushing, or breaking it. While Usimira Tablet ER can be administered with or without food, consistent timing is recommended.

How Usimira Tablet ER works:

Usimira Extended-Release tablets contain a beta-3 adrenergic agonist. This medication acts by stimulating bladder beta-3 receptors, resulting in detrusor muscle relaxation and consequently reducing urinary urgency, frequency, and incontinence.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when combining Usimira Extended-Release tablets and alcohol. Seek medical advice before doing so.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Usimira tablets might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Usimira Tablet likely poses a risk to breastfeeding infants. Available human data indicates potential transfer to breast milk, possibly causing infant harm.

DrivingDrivingSAFE

Driving ability is typically unaffected by Usimira Tablet ER.

KidneyKidneyCAUTION

For individuals with severe kidney impairment, Usimira Tablet ER requires careful administration. A modified dosage of Usimira Tablet ER might be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with hepatic impairment should use Usimira Tablet ER cautiously, potentially requiring dosage modification. Consult a physician before use. Usimira Tablet ER is contraindicated in those with severe liver disease.

What if you forget to take Usimira Tablet ER :

Should you forget to take a Usimira Tablet ER, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Usimira Tablet ER

LabelValue
Chemical Type Anilide-based compound
Developing Habits No.
Type of Therapy Urology
Actions Beta-3 agonist for bladder control

FAQs on Usimira Tablet ER

Usimira Tablet ER's full effects may become apparent after 8 weeks or more of treatment. Dosage adjustments may be considered after 4 to 8 weeks, depending on individual response.
Continue taking Usimira Tablet ER, even if your symptoms improve. It manages overactive bladder symptoms (urgency, frequency, and incontinence), not the condition itself. Discontinuing treatment could bring back your symptoms.
Usimira Tablet ER shouldn't interfere with your sleep. However, discuss any sleep problems with your doctor.
Usimira Tablet ER is not recommended for children under 18 due to a lack of studied efficacy and safety data in this age group.
No, consistent daily use, as prescribed, is crucial. This medication manages your condition, not cures it. Intermittent use prevents your bladder from fully adapting, hindering effectiveness and causing symptom recurrence.
Usimira Tablet ER may cause urinary tract infections (kidneys, ureters, bladder, or urethra), though this is not universal. Renal stones and bladder pain have been rarely reported. Patients with impaired kidney function should use caution and promptly report any kidney-related adverse effects to their doctor.
Caution is advised when taking Usimira Tablet ER if you have hypertension. Regular blood pressure monitoring is recommended, as Usimira Tablet ER may elevate blood pressure in some individuals. It's contraindicated in patients with severe, uncontrolled hypertension.
Seek immediate medical help, regardless of how you feel. Usimira Tablet ER overdose can raise heart rate and blood pressure, potentially causing severe headache, palpitations, chest pain, and fatigue.
Usimira Tablet ER
411
MRP 476
13% off